25 XP   0   0   10

Dimerix Ltd
Buy, Hold or Sell?

Let's analyse Dimerix together

PenkeI guess you are interested in Dimerix Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dimerix Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dimerix Ltd

I send you an email if I find something interesting about Dimerix Ltd.

Quick analysis of Dimerix (30 sec.)










What can you expect buying and holding a share of Dimerix? (30 sec.)

How much money do you get?

How much money do you get?
A$0.05
When do you have the money?
1 year
How often do you get paid?
36.4%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$-0.05
How sure are you?
63.6%

+ What do you gain per year?

Total Gains per Share
A$0.02
Return On Investment
5.0%

For what price can you sell your share?

Current Price per Share
A$0.32
Expected price per share
A$0.275 - A$0.37
How sure are you?
50%

1. Valuation of Dimerix (5 min.)




Live pricePrice per Share (EOD)

A$0.32

Intrinsic Value Per Share

A$-0.33 - A$-0.18

Total Value Per Share

A$-0.31 - A$-0.16

2. Growth of Dimerix (5 min.)




Is Dimerix growing?

Current yearPrevious yearGrowGrow %
How rich?$3.8m$9.3m-$5.4m-141.9%

How much money is Dimerix making?

Current yearPrevious yearGrowGrow %
Making money-$8.9m-$6.8m-$2.1m-24.0%
Net Profit Margin-153.6%-162.3%--

How much money comes from the company's main activities?

3. Financial Health of Dimerix (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#772 / 1010

Most Revenue
#337 / 1010

Most Profit
#539 / 1010

Most Efficient
#605 / 1010

What can you expect buying and holding a share of Dimerix? (5 min.)

Welcome investor! Dimerix's management wants to use your money to grow the business. In return you get a share of Dimerix.

What can you expect buying and holding a share of Dimerix?

First you should know what it really means to hold a share of Dimerix. And how you can make/lose money.

Speculation

The Price per Share of Dimerix is A$0.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dimerix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dimerix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dimerix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-5.1%-0.02-5.1%-0.01-3.9%-0.01-2.8%-0.01-1.7%
Usd Book Value Change Per Share-0.01-3.1%-0.01-3.1%0.024.8%0.00-0.1%0.000.1%
Usd Dividend Per Share0.013.9%0.013.9%0.000.0%0.001.5%0.000.7%
Usd Total Gains Per Share0.000.8%0.000.8%0.024.8%0.001.4%0.000.8%
Usd Price Per Share0.04-0.04-0.08-0.11-0.06-
Price to Earnings Ratio-2.47--2.47--6.29--16.91--12.73-
Price-to-Total Gains Ratio15.37-15.37-5.09--0.47-1.94-
Price to Book Ratio5.71-5.71-4.57-23.83-25.16-
Price-to-Total Gains Ratio15.37-15.37-5.09--0.47-1.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.207968
Number of shares4808
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (4808 shares)12.6022.18
Gains per Year (4808 shares)50.4188.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1243-1924093-479
2486-38590186-8168
3728-577140278-12257
4971-770190371-16346
51214-962240464-20435
61457-1154290557-24524
71700-1347340649-28613
81942-1539390742-33702
92185-1731440835-37791
102428-1924490928-41880

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.011.00.00.0%4.032.00.011.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.05.00.054.5%18.018.00.050.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%4.00.07.036.4%8.00.028.022.2%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.04.00.063.6%19.017.00.052.8%

Fundamentals of Dimerix

About Dimerix Ltd

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. The company is headquartered in Fitzroy, Australia.

Fundamental data was last updated by Penke on 2024-04-21 06:30:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Dimerix Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dimerix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dimerix to the Biotechnology industry mean.
  • A Net Profit Margin of -153.6% means that $-1.54 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dimerix Ltd:

  • The MRQ is -153.6%. The company is making a huge loss. -2
  • The TTM is -153.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-153.6%TTM-153.6%0.0%
TTM-153.6%YOY-162.3%+8.7%
TTM-153.6%5Y-170.2%+16.5%
5Y-170.2%10Y-368.8%+198.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-153.6%-207.2%+53.6%
TTM-153.6%-216.8%+63.2%
YOY-162.3%-282.3%+120.0%
5Y-170.2%-436.8%+266.6%
10Y-368.8%-597.3%+228.5%
1.1.2. Return on Assets

Shows how efficient Dimerix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dimerix to the Biotechnology industry mean.
  • -77.7% Return on Assets means that Dimerix generated $-0.78 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dimerix Ltd:

  • The MRQ is -77.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -77.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-77.7%TTM-77.7%0.0%
TTM-77.7%YOY-63.6%-14.1%
TTM-77.7%5Y-62.1%-15.6%
5Y-62.1%10Y-64.0%+1.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-77.7%-13.3%-64.4%
TTM-77.7%-12.8%-64.9%
YOY-63.6%-11.6%-52.0%
5Y-62.1%-13.8%-48.3%
10Y-64.0%-15.6%-48.4%
1.1.3. Return on Equity

Shows how efficient Dimerix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dimerix to the Biotechnology industry mean.
  • -231.5% Return on Equity means Dimerix generated $-2.31 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dimerix Ltd:

  • The MRQ is -231.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -231.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-231.5%TTM-231.5%0.0%
TTM-231.5%YOY-72.7%-158.7%
TTM-231.5%5Y-172.9%-58.5%
5Y-172.9%10Y-179.4%+6.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-231.5%-16.9%-214.6%
TTM-231.5%-16.1%-215.4%
YOY-72.7%-14.9%-57.8%
5Y-172.9%-19.3%-153.6%
10Y-179.4%-20.1%-159.3%

1.2. Operating Efficiency of Dimerix Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dimerix is operating .

  • Measures how much profit Dimerix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dimerix to the Biotechnology industry mean.
  • An Operating Margin of -254.1% means the company generated $-2.54  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dimerix Ltd:

  • The MRQ is -254.1%. The company is operating very inefficient. -2
  • The TTM is -254.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-254.1%TTM-254.1%0.0%
TTM-254.1%YOY-262.3%+8.3%
TTM-254.1%5Y-271.5%+17.4%
5Y-271.5%10Y-365.7%+94.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-254.1%-298.0%+43.9%
TTM-254.1%-238.5%-15.6%
YOY-262.3%-288.4%+26.1%
5Y-271.5%-486.2%+214.7%
10Y-365.7%-628.4%+262.7%
1.2.2. Operating Ratio

Measures how efficient Dimerix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.54 means that the operating costs are $2.54 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Dimerix Ltd:

  • The MRQ is 2.541. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.541. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.541TTM2.5410.000
TTM2.541YOY2.623-0.083
TTM2.5415Y2.715-0.174
5Y2.71510Y4.867-2.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5413.235-0.694
TTM2.5413.310-0.769
YOY2.6233.838-1.215
5Y2.7155.679-2.964
10Y4.8677.823-2.956

1.3. Liquidity of Dimerix Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dimerix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.51 means the company has $1.51 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Dimerix Ltd:

  • The MRQ is 1.510. The company is able to pay all its short-term debts. +1
  • The TTM is 1.510. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.510TTM1.5100.000
TTM1.510YOY8.148-6.638
TTM1.5105Y4.297-2.787
5Y4.29710Y10.162-5.865
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5103.863-2.353
TTM1.5104.169-2.659
YOY8.1485.337+2.811
5Y4.2976.122-1.825
10Y10.1626.434+3.728
1.3.2. Quick Ratio

Measures if Dimerix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dimerix to the Biotechnology industry mean.
  • A Quick Ratio of 1.49 means the company can pay off $1.49 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dimerix Ltd:

  • The MRQ is 1.492. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.492. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.492TTM1.4920.000
TTM1.492YOY7.914-6.421
TTM1.4925Y4.205-2.713
5Y4.20510Y9.949-5.744
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4923.504-2.012
TTM1.4923.991-2.499
YOY7.9145.371+2.543
5Y4.2056.088-1.883
10Y9.9496.395+3.554

1.4. Solvency of Dimerix Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dimerix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dimerix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.66 means that Dimerix assets are financed with 66.4% credit (debt) and the remaining percentage (100% - 66.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dimerix Ltd:

  • The MRQ is 0.664. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.664. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.664TTM0.6640.000
TTM0.664YOY0.126+0.538
TTM0.6645Y0.407+0.257
5Y0.40710Y0.306+0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6640.339+0.325
TTM0.6640.337+0.327
YOY0.1260.271-0.145
5Y0.4070.368+0.039
10Y0.3060.388-0.082
1.4.2. Debt to Equity Ratio

Measures if Dimerix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dimerix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 197.8% means that company has $1.98 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dimerix Ltd:

  • The MRQ is 1.978. The company is just able to pay all its debts with equity.
  • The TTM is 1.978. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.978TTM1.9780.000
TTM1.978YOY0.144+1.834
TTM1.9785Y1.610+0.368
5Y1.61010Y5.807-4.197
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9780.392+1.586
TTM1.9780.403+1.575
YOY0.1440.335-0.191
5Y1.6100.427+1.183
10Y5.8070.461+5.346

2. Market Valuation of Dimerix Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Dimerix generates.

  • Above 15 is considered overpriced but always compare Dimerix to the Biotechnology industry mean.
  • A PE ratio of -2.47 means the investor is paying $-2.47 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dimerix Ltd:

  • The EOD is -12.742. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.469. Based on the earnings, the company is expensive. -2
  • The TTM is -2.469. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.742MRQ-2.469-10.273
MRQ-2.469TTM-2.4690.000
TTM-2.469YOY-6.287+3.818
TTM-2.4695Y-16.912+14.444
5Y-16.91210Y-12.732-4.180
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.742-2.300-10.442
MRQ-2.469-2.656+0.187
TTM-2.469-2.718+0.249
YOY-6.287-4.145-2.142
5Y-16.912-6.258-10.654
10Y-12.732-6.315-6.417
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dimerix Ltd:

  • The EOD is -13.812. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.676. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.676. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.812MRQ-2.676-11.136
MRQ-2.676TTM-2.6760.000
TTM-2.676YOY-4.905+2.229
TTM-2.6765Y-16.364+13.688
5Y-16.36410Y-10.940-5.423
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.812-2.974-10.838
MRQ-2.676-3.306+0.630
TTM-2.676-3.508+0.832
YOY-4.905-5.613+0.708
5Y-16.364-8.378-7.986
10Y-10.940-8.873-2.067
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dimerix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.71 means the investor is paying $5.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Dimerix Ltd:

  • The EOD is 29.493. Based on the equity, the company is expensive. -2
  • The MRQ is 5.714. Based on the equity, the company is overpriced. -1
  • The TTM is 5.714. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD29.493MRQ5.714+23.779
MRQ5.714TTM5.7140.000
TTM5.714YOY4.573+1.141
TTM5.7145Y23.834-18.120
5Y23.83410Y25.156-1.322
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD29.4931.914+27.579
MRQ5.7142.116+3.598
TTM5.7142.097+3.617
YOY4.5732.881+1.692
5Y23.8343.550+20.284
10Y25.1563.936+21.220
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Dimerix Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Dimerix Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.015-0.0150%0.024-165%0.000-98%0.001-2286%
Book Value Per Share--0.0110.0110%0.026-59%0.012-12%0.008+32%
Current Ratio--1.5101.5100%8.148-81%4.297-65%10.162-85%
Debt To Asset Ratio--0.6640.6640%0.126+428%0.407+63%0.306+117%
Debt To Equity Ratio--1.9781.9780%0.144+1275%1.610+23%5.807-66%
Dividend Per Share--0.0190.0190%0.000+763581%0.007+162%0.003+476%
Eps---0.025-0.0250%-0.019-24%-0.014-45%-0.008-67%
Free Cash Flow Per Share---0.023-0.0230%-0.024+6%-0.015-37%-0.009-63%
Free Cash Flow To Equity Per Share---0.003-0.0030%0.008-139%0.004-180%0.003-215%
Gross Profit Margin--1.0011.0010%1.0030%1.027-3%1.031-3%
Intrinsic Value_10Y_max---0.175--------
Intrinsic Value_10Y_min---0.325--------
Intrinsic Value_1Y_max---0.011--------
Intrinsic Value_1Y_min---0.023--------
Intrinsic Value_3Y_max---0.037--------
Intrinsic Value_3Y_min---0.078--------
Intrinsic Value_5Y_max---0.070--------
Intrinsic Value_5Y_min---0.142--------
Market Cap175868805.120+81%34074580.99234074580.9920%65950801.920-48%89253418.598-62%47424622.108-28%
Net Profit Margin---1.536-1.5360%-1.623+6%-1.702+11%-3.688+140%
Operating Margin---2.541-2.5410%-2.623+3%-2.715+7%-3.657+44%
Operating Ratio--2.5412.5410%2.623-3%2.715-6%4.867-48%
Pb Ratio29.493+81%5.7145.7140%4.573+25%23.834-76%25.156-77%
Pe Ratio-12.742-416%-2.469-2.4690%-6.287+155%-16.912+585%-12.732+416%
Price Per Share0.320+81%0.0620.0620%0.120-48%0.162-62%0.086-28%
Price To Free Cash Flow Ratio-13.812-416%-2.676-2.6760%-4.905+83%-16.364+511%-10.940+309%
Price To Total Gains Ratio79.337+81%15.37215.3720%5.091+202%-0.474+103%1.938+693%
Quick Ratio--1.4921.4920%7.914-81%4.205-65%9.949-85%
Return On Assets---0.777-0.7770%-0.636-18%-0.621-20%-0.640-18%
Return On Equity---2.315-2.3150%-0.727-69%-1.729-25%-1.794-23%
Total Gains Per Share--0.0040.0040%0.024-83%0.007-43%0.004-1%
Usd Book Value--3875431.0383875431.0380%9373273.736-59%4395455.542-12%2926562.918+32%
Usd Book Value Change Per Share---0.010-0.0100%0.015-165%0.000-98%0.000-2286%
Usd Book Value Per Share--0.0070.0070%0.017-59%0.008-12%0.005+32%
Usd Dividend Per Share--0.0130.0130%0.000+763581%0.005+162%0.002+476%
Usd Eps---0.016-0.0160%-0.012-24%-0.009-45%-0.005-67%
Usd Free Cash Flow---8275048.670-8275048.6700%-8738913.495+6%-5216213.342-37%-2820641.743-66%
Usd Free Cash Flow Per Share---0.015-0.0150%-0.016+6%-0.009-37%-0.006-63%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%0.005-139%0.002-180%0.002-215%
Usd Market Cap114297136.447+81%22145070.18722145070.1870%42861426.168-48%58005796.747-62%30821261.908-28%
Usd Price Per Share0.208+81%0.0400.0400%0.078-48%0.106-62%0.056-28%
Usd Profit---8970452.068-8970452.0680%-6817827.292-24%-4945154.870-45%-2942335.754-67%
Usd Revenue--5838530.6765838530.6760%4200599.405+39%3077309.125+90%1554720.262+276%
Usd Total Gains Per Share--0.0030.0030%0.015-83%0.005-43%0.003-1%
 EOD+6 -2MRQTTM+0 -0YOY+11 -255Y+9 -2710Y+13 -23

4.2. Fundamental Score

Let's check the fundamental score of Dimerix Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.742
Price to Book Ratio (EOD)Between0-129.493
Net Profit Margin (MRQ)Greater than0-1.536
Operating Margin (MRQ)Greater than0-2.541
Quick Ratio (MRQ)Greater than11.492
Current Ratio (MRQ)Greater than11.510
Debt to Asset Ratio (MRQ)Less than10.664
Debt to Equity Ratio (MRQ)Less than11.978
Return on Equity (MRQ)Greater than0.15-2.315
Return on Assets (MRQ)Greater than0.05-0.777
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Dimerix Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.330
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets17,758
Total Liabilities11,794
Total Stockholder Equity5,963
 As reported
Total Liabilities 11,794
Total Stockholder Equity+ 5,963
Total Assets = 17,758

Assets

Total Assets17,758
Total Current Assets17,751
Long-term Assets6
Total Current Assets
Cash And Cash Equivalents 7,992
Net Receivables 9,554
Other Current Assets 206
Total Current Assets  (as reported)17,751
Total Current Assets  (calculated)17,751
+/-0
Long-term Assets
Property Plant Equipment 6
Long-term Assets  (as reported)6
Long-term Assets  (calculated)6
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,756
Long-term Liabilities38
Total Stockholder Equity5,963
Total Current Liabilities
Short-term Debt 5,958
Short Long Term Debt 5,936
Accounts payable 5,137
Other Current Liabilities 661
Total Current Liabilities  (as reported)11,756
Total Current Liabilities  (calculated)17,692
+/- 5,936
Long-term Liabilities
Other Liabilities 38
Long-term Liabilities  (as reported)38
Long-term Liabilities  (calculated)38
+/-0
Total Stockholder Equity
Common Stock55,489
Retained Earnings -52,101
Accumulated Other Comprehensive Income 2,575
Total Stockholder Equity (as reported)5,963
Total Stockholder Equity (calculated)5,963
+/-0
Other
Capital Stock55,489
Cash And Equivalents7,992
Cash and Short Term Investments 7,992
Common Stock Shares Outstanding 325,529
Current Deferred Revenue-5,958
Liabilities and Stockholders Equity 17,758
Net Debt -2,034
Net Invested Capital 11,899
Net Tangible Assets 5,963
Net Working Capital 5,995
Property Plant and Equipment Gross 40
Short Long Term Debt Total 5,958



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302014-04-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
1,781
1,727
1,149
1,161
1,636
2,033
1,981
2,244
2,261
9,690
9,121
7,902
2,278
1,891
1,216
1,828
10,521
3,038
4,072
2,449
385
1,607
1,594
1,214
1,753
1,762
1,214
2,969
2,525
2,872
7,265
4,941
10,389
9,421
16,497
17,758
17,75816,4979,42110,3894,9417,2652,8722,5252,9691,2141,7621,7531,2141,5941,6073852,4494,0723,03810,5211,8281,2161,8912,2787,9029,1219,6902,2612,2441,9812,0331,6361,1611,1491,7271,781
   > Total Current Assets 
387
240
246
267
88
104
62
187
207
4,577
3,115
2,448
1,513
1,145
625
1,388
2,405
1,166
730
599
383
1,178
1,594
1,214
1,753
1,759
1,214
2,964
2,523
2,869
7,264
4,938
10,388
9,419
16,488
17,751
17,75116,4889,41910,3884,9387,2642,8692,5232,9641,2141,7591,7531,2141,5941,1783835997301,1662,4051,3886251,1451,5132,4483,1154,5772071876210488267246240387
       Cash And Cash Equivalents 
21
10
8
213
30
80
47
173
82
1,280
87
17
245
42
51
136
2,236
1,134
446
118
372
1,164
1,032
154
1,153
1,673
1,199
2,931
2,019
2,245
6,284
3,563
7,786
5,250
9,630
7,992
7,9929,6305,2507,7863,5636,2842,2452,0192,9311,1991,6731,1531541,0321,1643721184461,1342,236136514224517871,2808217347803021381021
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
300
0
0
0
0
0
0
0
0
424
1,030
594
0
0
0
0
0
0
0
0
0
0
0
000000000005941,030424000000003000000000000000
       Net Receivables 
366
230
238
54
58
24
15
14
125
2,105
1,460
1,464
809
551
323
401
169
32
147
119
11
14
138
30
7
86
3
21
459
577
903
1,275
2,464
4,008
6,385
9,554
9,5546,3854,0082,4641,275903577459213867301381411119147321694013235518091,4641,4602,1051251415245854238230366
       Other Current Assets 
0
0
0
0
0
0
0
0
60
0
1
0
4
300
0
119
0
0
54
191
0
0
15
15
0
0
11
11
504
624
980
1,375
138
161
474
206
2064741611381,3759806245041111001515001915400119030040106000000000
   > Long-term Assets 
1,394
1,487
903
894
1,548
1,929
1,919
2,057
2,054
5,113
6,007
5,454
765
746
592
440
8,116
1,872
3,341
1,849
3
429
0
0
0
0
3
5
2
3
0
3
1
1
9
6
6911303253000042931,8493,3411,8728,1164405927467655,4546,0075,1132,0542,0571,9191,9291,5488949031,4871,394
       Property Plant Equipment 
803
896
880
870
1,548
1,929
1,919
2,057
2,054
2,675
3,631
3,456
765
626
209
531
5
23
17
17
3
0
0
0
0
3
3
5
2
3
0
3
1
1
9
6
691130325330000317172355312096267653,4563,6312,6752,0542,0571,9191,9291,548870880896803
       Goodwill 
0
0
0
0
0
0
0
0
0
2,224
2,111
1,998
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000001,9982,1112,224000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
2,225
2,111
1,998
0
47
38
13
8,110
0
3,324
1,832
0
0
0
11,962
0
0
0
0
0
0
0
0
0
0
0
0
00000000000011,9620001,8323,32408,11013384701,9982,1112,225000000000
       Long-term Assets Other 
591
591
0
0
0
0
0
0
0
213
265
0
0
322
336
339
0
0
0
0
0
0
0
0
0
0
-3
0
-2
-3
0
-3
-1
-1
-9
-6
-6-9-1-1-30-3-20-30000000000339336322002652130000000591591
> Total Liabilities 
256
318
103
117
226
292
257
394
303
4,664
3,350
2,661
1,638
1,608
1,781
1,998
240
344
2,657
1,440
43
46
28
35
46
1,731
34
192
283
242
407
738
2,630
7,952
2,074
11,794
11,7942,0747,9522,630738407242283192341,73146352846431,4402,6573442401,9981,7811,6081,6382,6613,3504,664303394257292226117103318256
   > Total Current Liabilities 
26
74
80
103
83
96
61
228
167
3,179
3,082
2,390
1,595
1,320
1,232
1,190
240
344
1,498
1,440
43
46
28
35
46
1,731
34
192
283
242
407
738
2,630
7,952
2,024
11,756
11,7562,0247,9522,630738407242283192341,73146352846431,4401,4983442401,1901,2321,3201,5952,3903,0823,179167228619683103807426
       Short-term Debt 
0
6
8
10
2
0
0
166
34
1,361
1,839
1,377
75
216
11
10
10
10
951
1,018
0
0
424
1,030
594
0
0
0
0
0
0
1,094
1,055
5,043
52
5,958
5,958525,0431,0551,0940000005941,030424001,01895110101011216751,3771,8391,3613416600210860
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,063
5,050
0
5,936
5,93605,0501,06300000000000000000000000000000000
       Accounts payable 
20
67
48
76
23
30
21
17
96
881
825
1,079
1,331
986
1,142
1,110
81
266
470
422
22
46
28
35
6
103
2
136
133
83
269
417
1,149
2,520
1,111
5,137
5,1371,1112,5201,149417269831331362103635284622422470266811,1101,1429861,3311,079825881961721302376486720
       Other Current Liabilities 
6
7
32
27
24
30
5
9
0
2,361
2,567
1,852
606
11
630
523
149
68
169
80
21
12
9
11
41
1,628
32
56
149
159
137
321
425
389
861
661
66186138942532113715914956321,6284111912218016968149523630116061,8522,5672,3610953024273276
   > Long-term Liabilities 
230
244
23
14
143
196
196
166
136
1,485
268
272
42
288
549
808
0
0
1,159
0
0
0
0
0
0
0
0
0
0
0
0
417
2,243
51
51
38
3851512,2434170000000000001,15900808549288422722681,4851361661961961431423244230
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
0
0210000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
25
26
23
23
24
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
38
3830000000000000000000242323262500000000000
> Total Stockholder Equity
1,525
1,409
1,046
1,044
1,410
1,741
1,724
1,850
1,958
5,026
5,772
5,240
640
283
-565
-170
10,281
2,694
1,415
1,008
342
1,560
1,566
1,180
1,707
31
1,179
2,777
2,243
2,630
6,858
4,203
7,759
1,468
14,423
5,963
5,96314,4231,4687,7594,2036,8582,6302,2432,7771,179311,7071,1801,5661,5603421,0081,4152,69410,281-170-5652836405,2405,7725,0261,9581,8501,7241,7411,4101,0441,0461,4091,525
   Common Stock
756
756
756
756
830
914
1,029
1,140
1,394
2,557
4,713
4,714
4,713
5,144
5,292
6,389
17,436
20,244
21,300
24,332
27,834
29,400
29,400
29,400
30,286
3,038
30,286
31,558
10,920
13,013
20,287
20,475
28,344
28,389
50,895
55,489
55,48950,89528,38928,34420,47520,28713,01310,92031,55830,2863,03830,28629,40029,40029,40027,83424,33221,30020,24417,4366,3895,2925,1444,7134,7144,7132,5571,3941,1401,029914830756756756756
   Retained Earnings 
588
469
125
124
59
-78
-201
-325
-465
-254
92
-424
-4,108
-4,974
-5,943
-6,619
-7,155
-18,316
-20,126
-23,504
-27,552
-27,862
-27,857
-28,220
-28,737
-3,007
-29,265
-29,945
-8,977
-10,736
-14,055
-16,942
-21,436
-27,808
-38,298
-52,101
-52,101-38,298-27,808-21,436-16,942-14,055-10,736-8,977-29,945-29,265-3,007-28,737-28,220-27,857-27,862-27,552-23,504-20,126-18,316-7,155-6,619-5,943-4,974-4,108-42492-254-465-325-201-7859124125469588
   Capital Surplus 000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000
   Other Stockholders Equity 
181
184
165
193
532
918
910
1,048
0
1
-1,734
-1
-150
-42
0
0
7
0
0
152
0
0
0
0
-5,636
0
0
0
300
353
626
670
-6,908
-582
-12,597
-3,388
-3,388-12,597-582-6,908670626353300000-5,636000015200700-42-150-1-1,734101,048910918532193165184181



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue8,984
Cost of Revenue-56
Gross Profit8,9288,928
 
Operating Income (+$)
Gross Profit8,928
Operating Expense-22,767
Operating Income-22,823-13,840
 
Operating Expense (+$)
Research Development20,474
Selling General Administrative2,281
Selling And Marketing Expenses13
Operating Expense22,76722,767
 
Net Interest Income (+$)
Interest Income37
Interest Expense--
Other Finance Cost-0
Net Interest Income37
 
Pretax Income (+$)
Operating Income-22,823
Net Interest Income37
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-22,737-22,909
EBIT - interestExpense = -22,823
-22,737
-13,803
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-22,823-22,737
Earnings Before Interest and Taxes (EBITDA)-22,767
 
After tax Income (+$)
Income Before Tax-22,737
Tax Provision-0
Net Income From Continuing Ops-13,803-22,737
Net Income-13,803
Net Income Applicable To Common Shares-13,803
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses22,823
Total Other Income/Expenses Net86-37
 

Technical Analysis of Dimerix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dimerix. The general trend of Dimerix is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dimerix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dimerix Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.345 < 0.37.

The bearish price targets are: 0.3225 > 0.275 > 0.275.

Tweet this
Dimerix Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dimerix Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dimerix Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dimerix Ltd.

Dimerix Ltd Daily Moving Average Convergence/Divergence (MACD) ChartDimerix Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dimerix Ltd. The current adx is .

Dimerix Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dimerix Ltd.

Dimerix Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dimerix Ltd.

Dimerix Ltd Daily Relative Strength Index (RSI) ChartDimerix Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dimerix Ltd.

Dimerix Ltd Daily Stochastic Oscillator ChartDimerix Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dimerix Ltd.

Dimerix Ltd Daily Commodity Channel Index (CCI) ChartDimerix Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dimerix Ltd.

Dimerix Ltd Daily Chande Momentum Oscillator (CMO) ChartDimerix Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dimerix Ltd.

Dimerix Ltd Daily Williams %R ChartDimerix Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dimerix Ltd.

Dimerix Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dimerix Ltd.

Dimerix Ltd Daily Average True Range (ATR) ChartDimerix Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dimerix Ltd.

Dimerix Ltd Daily On-Balance Volume (OBV) ChartDimerix Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dimerix Ltd.

Dimerix Ltd Daily Money Flow Index (MFI) ChartDimerix Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dimerix Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Dimerix Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dimerix Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.330
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dimerix with someone you think should read this too:
  • Are you bullish or bearish on Dimerix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dimerix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dimerix Ltd

I send you an email if I find something interesting about Dimerix Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Dimerix Ltd.

Receive notifications about Dimerix Ltd in your mailbox!